A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 24, 2023

Primary Completion Date

May 16, 2024

Study Completion Date

May 16, 2024

Conditions
Type 1 Diabetes MellitusType 1 Diabetes Mellitus with HypoglycemiaType 1 Diabetes Mellitus with Hyperglycemia
Interventions
DEVICE

Lab Demo 1.0

"Lowering of the participants blood glucose with the application of insulin to induce hypoglycaemia, followed by the application of glucose to induce hyperglycaemia and finally insulin to restore euglycemia.~During the different glycaemia states, transcutaneous spectral data are collected continuously with the device and paired with reference measurements (venous blood and interstitial fluid)."

Trial Locations (1)

3010

Markus Laimer, Bern

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

DCB Research AG

OTHER

lead

Liom Health AG

INDUSTRY

NCT06097689 - A Pilot Study to Assess the Feasibility of a Novel Non-invasive Technology to Measure Changing Blood Glucose Levels in Adults with Type-1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter